Institution
Nagoya University
Also known as: Nagoya Daigaku · 名古屋大学
- 5running trials
- 1closed trial
- 314,213publications (OpenAlex)
Running trials
Recruiting
The Clinical Trial of Tamibarotene for Patients With HFpEF (RELIEF Trial)
Recruiting
Recruiting
Recruiting
Recruiting
Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Heart failure1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Registry name variants (2)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Nagoya University
Nagoya, 4668560
4 trials
Nagoya University Graduate School of Medicine
Nagoya
2 trials
Contact: Lieke van den Wildenberg
Contact: Keisuke Uehara
Conditions
Diseases this institution publishes on or runs trials for.
- Chronic kidney disease46 works · 0 trials
- Pancreatic cancer42 works · 1 trial
- Ovarian cancer29 works · 0 trials
- ALS (motor neurone disease)24 works · 0 trials
- Myocarditis13 works · 0 trials
- Nephrotic syndrome12 works · 0 trials
- Osteonecrosis (avascular necrosis)10 works · 0 trials
- Cerebral palsy9 works · 0 trials
- Mesothelioma9 works · 0 trials
- Sarcoidosis8 works · 0 trials
- Lewy body dementia7 works · 0 trials
- Dermatomyositis and polymyositis (myositis)6 works · 0 trials
- Retinitis pigmentosa5 works · 0 trials
- Polycystic kidney disease4 works · 0 trials
- Thymoma and thymic carcinoma4 works · 0 trials
Institution data: ROR 04chrp450 (CC0-1.0)Updated 14 Nov 2026